Klass Russell Kevin's Form 4 filing
Zomedica Corp. (ZOMDF) · filed Mar 18, 2025
- Accession no.
- 0001654954-25-002954
- Filed
- Mar 18, 2025, 4:36 PM ET
- Trade date
- Mar 17, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $49.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Klass Russell KevinCIK 0001999774 | Officer (Sr Vice President of Sales) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 17, 2025 | Common Stock, without $0.070 par value | PPurchaseAcquired | +699,980 | $0.07 | +$48,998.6 | 3,200,030 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.